ANGIE SCHERRER: Open Payments
NPI 1427784180 · HOCKESSIN, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,751 in 89 payments from 25 companies in 2025. Trend: 2023 $1,079 · 2024 $1,847 · 2025 $1,751
Food & beverage: $1,751
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $226 |
| ABBVIE INC. | 10 | $204 |
| Abbott Laboratories | 8 | $143 |
| GlaxoSmithKline, LLC. | 9 | $140 |
| Corcept Therapeutics | 4 | $126 |
| Novo Nordisk Inc | 7 | $122 |
| Astellas Pharma US Inc | 4 | $93 |
| SANOFI-AVENTIS U.S. LLC | 4 | $90 |
| Lilly USA, LLC | 5 | $89 |
| Amgen Inc. | 5 | $87 |
Products named: FREESTYLE LIBRE 3, Korlym, QULIPTA, TZIELD, BREZTRI, Veozah, VRAYLAR, JARDIANCE.
Industry payments across DE — which companies pay providers there.
